Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transtracheal oxygen therapy for refractory hypoxemia.

K L Christopher, B T Spofford, P K Brannin

    JAMA
    |July 25, 1986
    PubMed
    Summary

    New transtracheal oxygen catheters effectively treated chronic severe hypoxemia in eight patients. This therapy improved oxygen levels and reduced flow needs, enhancing quality of life.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Staying Active With COPD.

    The Physician and sportsmedicine·2016
    Same author

    Chronic lung disease.

    Postgraduate medicine·2016
    Same author

    Emphysema.

    Postgraduate medicine·2016
    Same author

    Differences in vitamin D nutritional status between newly diagnosed cancer patients from rural or urban settings in Kentucky.

    Nutrition and cancer·2013
    Same author

    Can Anything be Done for Emphysema?

    Canadian family physician Medecin de famille canadien·2010
    Same author

    Long-term oxygen therapy.

    The European respiratory journal·2005

    Area of Science:

    • Pulmonary Medicine
    • Respiratory Therapy

    Background:

    • Chronic severe and refractory hypoxemia significantly impacts patient quality of life.
    • High-flow nasal cannula therapy is often insufficient for severe hypoxemia.

    Observation:

    • Eight patients with severe hypoxemia (PaO2 < 55 mm Hg) on high-flow nasal cannula were studied.
    • A novel transtracheal oxygen catheter was implemented for treatment.

    Findings:

    • Transtracheal oxygen therapy (2.5–6.0 L/min) successfully improved arterial oxygen partial pressure by over 50%.
    • Oxygen flow requirements decreased by 72% with transtracheal oxygen.
    • No procedural complications were observed, and high flow rates were well-tolerated.

    Implications:

    • Transtracheal oxygen therapy offers a viable solution for refractory hypoxemia.
    • The therapy demonstrated potential for long-term clinical stability and improved quality of life in some patients.
    • Further research into long-term outcomes and patient selection is warranted.

    Related Experiment Videos